Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy

Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy

Alessandro Giunta,1,* Alessandra Ventura,1,* Maria Sole Chimenti,2 Luca Bianchi,1 Maria Esposito1 1Department of Dermatology, 2Department of Rheumatology, University of Rome Tor Vergata, Rome, Italy *These authors contributed equally to this manuscript Abstract: Psoriasis is a chronic inflammator...

Full description

Bibliographic Details
Main Authors: Giunta A, Ventura A, Chimenti MS, Bianchi L, Esposito M
Format: Article
Language:English
Published: Dove Medical Press 2017-06-01
Series:Drug Design, Development and Therapy
Subjects:
Biologic therapies
IL-17
Ixekizumab
Psoriasis.
Online Access:https://www.dovepress.com/spotlight-on-ixekizumab-for-the-treatment-of-moderate-to-severe-plaque-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/spotlight-on-ixekizumab-for-the-treatment-of-moderate-to-severe-plaque-peer-reviewed-article-DDDT

Similar Items